Form 4: STERIS Executive Julia Madsen Reports Share Withholding

Senior VP Julia Madsen reported the withholding of 239 shares to cover tax obligations following the vesting of restricted stock.

Summary

• Julia Madsen, Senior VP and GM of Life Sciences at STERIS plc, reported a transaction involving the withholding of 239 ordinary shares.
• The transaction occurred on June 3, 2026, at a price of $210.19 per share.
• The withholding was executed to satisfy tax obligations related to the vesting of 666 restricted shares.
• Following this transaction, the reporting person maintains a direct beneficial ownership of 12,452 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax withholding rather than a change in executive sentiment or company performance.

Positives

• The transaction is a routine administrative action related to tax withholding upon the vesting of equity awards, rather than a discretionary sale.

Negatives

• None identified; this is a standard regulatory disclosure for executive compensation.

Risks

• None identified; this filing pertains to routine equity compensation management.

Future Outlook

Not applicable; this is a historical transaction report.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory requirement for corporate insiders and does not reflect a change in company strategy or market outlook.

Comparison to Industry Standards

• The practice of withholding shares to cover tax liabilities upon the vesting of restricted stock units is a standard industry practice for publicly traded companies.

Stakeholder Impact

• No material impact on shareholders or other stakeholders.

Next Steps

• Future vesting of restricted shares as per the disclosed schedule.

Key Dates

Keywords

STERIS, STE, Form 4, Insider Trading, Equity Compensation, Life Sciences